ReviewUpdates in surgery2025
RAPID procedure in patients with cirrhosis with or without hepatocellular cancer: a brief selection of candidates and a detailed description of the techniques.
Review in Updates in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The RAPID technique, i.e., Resection And Partial Liver Transplantation With Delayed Total Hepatectomy, represents one of the latest advancements in the field, recently discussed at the Zurich consensus meeting of the ISLS (International Society of Liver Surgeons).RAPID can be applied in the setting of either liver metastases developed on normal liver or of cirrhosis with or without hepatocellular carcinoma (HCC). RAPID for cirrhosis represents a stepwise evolution however, two main characteristics distinguish the RAPID technique in healthy liver from RAPID for cirrhosis: first, the functional reserve of the native cirrhotic liver is limited that is difficult to accurately estimate preoperatively, and second, existing portal hypertension (PHT) related to the cirrhosis complicates parenchymal transection and may also injure the implanted small graft. In this paper, we will describe the selection of the best candidates and the RAPID technique for cirrhosis. The measurement and modulation modalities of the portal flow will be particularly addressed.
Indexed as
Identifiers
40751861What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.